| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |